Event Date/Time: Sep 07, 2012
End Date/Time: Sep 09, 2012
Keeping up to date with developments and new ideas in the treatment of viral hepatitis presents a major challenge to treating physicians, healthcare providers and researchers. Objective scientific assessment of new drug treatments and therapeutic strategies is therefore essential. It will be the aim of the Viral Hepatitis Congress to provide a wide-ranging yet accessible forum for such assessment.
No. of delegates: 800
Specialties: Hepatology, Infectious disease, Gastroenterology